Bank of Montreal
CBAY

Bank of Montreal’s Cymabay Therapeutics CBAY Stock Holding History

Bank of Montreal’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-56,276
Closed -$354K – 4332
2022
Q4 		$354K Buy
+56,276
New +$214K ﹤0.01% 2815
2022
Q1 		– Sell
-16,904
Closed -$56K – 4330
2021
Q4 		$56K Sell
16,904
-2
-0% -$8 ﹤0.01% 3225
2021
Q3 		$65K Buy
+16,906
New +$66.6K ﹤0.01% 3520
2021
Q2 		– Sell
-9,759
Closed -$42K – 5143
2021
Q1 		$42K Sell
9,759
-8,771
-47% -$47.2K ﹤0.01% 3784
2020
Q4 		$121K Buy
18,530
+7,510
+68% +$56.8K ﹤0.01% 3488
2020
Q3 		$80K Sell
11,020
-2,289
-17% -$12.2K ﹤0.01% 3209
2020
Q2 		$44K Buy
13,309
+11,642
+698% +$33.6K ﹤0.01% 3495
2020
Q1 		$2K Sell
1,667
-7,080
-81% -$11.9K ﹤0.01% 3904
2019
Q4 		$17K Sell
8,747
-52,130
-86% -$196K ﹤0.01% 4394
2019
Q3 		$312K Buy
60,877
+54,106
+799% +$328K ﹤0.01% 2676
2019
Q2 		$48K Buy
6,771
+6,311
+1,372% +$71.5K ﹤0.01% 3723
2019
Q1 		$6K Sell
460
-368
-44% -$3.91K ﹤0.01% 4006
2018
Q4 		$7K Buy
828
+232
+39% +$2.21K ﹤0.01% 3996
2018
Q3 		$7K Buy
596
+178
+43% +$2.21K ﹤0.01% 4045
2018
Q2 		$6K Buy
+418
New +$5.23K ﹤0.01% 4098

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of Montreal's CBAY Position: Q1 2023 in Review

Bank of Montreal sold out of Cymabay Therapeutics (CBAY) in Q1 2023, closing a stake of 56,276 shares — an estimated $354K sold.

Bank of Montreal first reported a position in CBAY in Q2 2018 and held it in 15 quarters. The position peaked at $354K in Q4 2022. 139 funds tracked by Wall St. Rank hold CBAY as of Q1 2023.

  • Bank of Montreal reported no remaining Cymabay Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Bank of Montreal sold 56,276 Cymabay Therapeutics shares in Q1 2023, an estimated $354K.
  • Bank of Montreal first reported a position in Cymabay Therapeutics in Q2 2018 and held it in 15 quarters.
  • Bank of Montreal's Cymabay Therapeutics position peaked at $354K in Q4 2022.
  • 139 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.